Welcome to our dedicated page for Alpha Cognition SEC filings (Ticker: ACOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alpha Cognition Inc. (NASDAQ: ACOG) SEC filings page on Stock Titan provides centralized access to the company’s U.S. regulatory disclosures. Alpha Cognition is an emerging growth, commercial-stage biopharmaceutical company focused on Alzheimer’s disease and other neurodegenerative conditions, and its filings offer detailed insight into how it finances, governs, and reports on its ZUNVEYL and ALPHA-1062 programs.
Through this page, users can review Current Reports on Form 8-K that document material events such as public offerings of common shares and pre-funded warrants, at-the-market offering agreements, changes in the independent registered public accounting firm, and adoption of equity incentive plans. For example, recent 8-Ks describe an underwriting agreement for a public offering intended to support ZUNVEYL commercialization, an ATM agreement with a sales agent for up to a specified aggregate amount of common shares, and the transition from a Canada-based auditor to a U.S.-licensed firm following relocation of principal executive offices to Texas.
Investors can also use this page to monitor corporate governance and compensation matters, including shareholder votes on the number of directors, director elections, ratification of auditors, and approval of stock incentive plans, as reported in meeting-related filings. These documents help clarify how Alpha Cognition structures its board, aligns management incentives, and complies with exchange and securities regulations.
Stock Titan enhances these filings with AI-powered summaries that highlight key terms, financial implications, and governance changes, reducing the time needed to interpret lengthy documents. Real-time integration with the SEC’s EDGAR system means new ACOG filings appear promptly, while dedicated sections for material agreements and capital markets activity make it easier to follow offerings, ATM usage, and other financing tools. For users interested in deeper due diligence on Alpha Cognition’s Alzheimer’s-focused business, this page serves as a structured entry point into the company’s official regulatory record.
Alpha Cognition Inc. had an amended insider ownership report filed by Opaleye Management Inc., a more than ten percent owner. The filing shows indirect holdings of 2,125,000 shares of common stock through Opaleye, L.P. and 68,589 shares through a managed account. Opaleye Management Inc. disclaims beneficial ownership of these shares except to the extent of its pecuniary interest.
Alpha Cognition Inc. ownership update: Opaleye Management Inc., Opaleye, L.P. and James Silverman report shared beneficial ownership of 2,193,589 common shares, equal to 10.09% of the class. The filing states the Adviser has shared voting and dispositive power and cites November 13, 2025 for a 21,742,104 shares outstanding reference.
Alpha Cognition Inc. received an initial ownership report on Form 3 from Opaleye Management Inc., identified as a ten percent owner. The filing shows indirect holdings of 2,193,589 shares of common stock through Opaleye, L.P. and 75,000 shares through a managed account. Opaleye Management Inc. states it may be deemed to beneficially own these securities as investment manager but disclaims beneficial ownership except to the extent of its pecuniary interest.
Alpha Cognition Inc. reports amended beneficial ownership by Opaleye-related filers. The amendment states Opaleye Management Inc., Opaleye, L.P. and James Silverman beneficially own 2,268,589 common shares, representing 10.43% of the class.
The filing notes 2,193,589 shares held by Opaleye, L.P., and cites November 13, 2025 as the source for 21,742,104 shares outstanding reported in the company’s Form 10-Q. The advisers indicate additional managed-account holdings may be attributable to the Adviser and Mr. Silverman.
Alpha Cognition Inc. Schedule 13G discloses that Funicular Funds, LP; its GP Cable Car Capital, LP; and Jacob Ma-Weaver each report beneficial ownership of 1,114,747 shares of common stock, representing 5.1% of the class. The ownership calculation references 21,742,104 shares outstanding as of November 13, 2025.
The filing lists sole voting and dispositive power for each reporting person over the 1,114,747 shares. Signatures show Jacob Ma-Weaver as the managing member signing on February 19, 2026.
Alpha Cognition Inc. reports beneficial ownership by Funicular Funds, Cable Car Capital and Jacob Ma-Weaver of 1,060,212 shares, representing 4.9% of Common Stock based on 21,742,104 shares outstanding reported in the Form 10-Q dated November 13, 2025. The filing lists identical holdings for Funicular Funds, LP; Cable Car Capital, LP; and Jacob Ma-Weaver, each shown with 1,060,212 shares and sole voting and dispositive power. The signatures are dated February 18, 2026.
Alpha Cognition Inc. shareholder Ikarian Capital, LLC reported beneficial ownership of 1,056,259 common shares, equal to 4.9% of Alpha Cognition’s outstanding stock. The stake is held through Ikarian Healthcare Master Fund, L.P. and certain separately managed accounts.
The 4.9% figure is based on 21,742,104 common shares outstanding as of November 13, 2025. The reporting persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Alpha Cognition.
Alpha Cognition Inc. received a new Schedule 13G reporting a 5.1% passive stake in its common shares. Manchester Management Company, LLC and Manchester Management PR, LLC each report beneficial ownership of 1,127,181 common shares, representing 5.1% of the class as of 12/30/2025.
The firms report shared voting and dispositive power over all 1,127,181 shares and no sole power. All securities are directly owned by advisory clients of Manchester Management PR, LLC, and no individual client is deemed to own more than 5% of the class. The reporting persons certify the holdings are not for the purpose of changing or influencing control of Alpha Cognition.
Investment Company, Inc., a Delaware investment adviser, reports beneficial ownership of 2,172,036 Alpha Cognition Inc. common shares and pre-funded warrants, representing 9.9% of the class as of 12/31/2025. It has sole voting and dispositive power over these securities through several affiliated funds.
The position is held for ordinary course investment purposes and is not aimed at changing or influencing control of Alpha Cognition. The pre-funded warrants may only be exercised to the extent total beneficial ownership does not exceed 9.99% of Alpha Cognition’s outstanding common shares.
Alpha Cognition Inc. received a Schedule 13G reporting a significant shareholder position by Opaleye-related entities. Opaleye Management Inc., Opaleye, L.P., and James Silverman report beneficial ownership of 2,070,784 shares of Alpha Cognition common stock, representing 9.52% of the class as of 12/31/2025.
Most of the position, 2,015,784 shares or 9.27% of the class, is held by Opaleye, L.P. The filer reports shared voting and shared dispositive power over 2,070,784 shares and no sole power. The reporting persons certify the holdings are not for the purpose of changing or influencing control of the company.